May 18 - ASCO Abstracts available June 3-7 ASCO 2011 (Rida presents data on endometrial, breast, and sarcoma/Ponatinib AML presentation) July 3-7 14th Annual World Conference on Lung Cancer (AP113 update) Rida NDA filing/$25mm milestone payment New Rida P3 Trials (Endometrial (Rida), Breast (Rida+DALO) AP113 Phase 1 trial start Ponatinib reaches full enrollment (early Fall) December 10-13 ASH (Ponatinib update) Rida Approval Ponatinib NDA AP113 first interim data
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.